Micro Emerging Active

LTRN FDA clears Investigational New Drug application for STAR-001

Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1

Summary

An article belongs to this narrative if it discusses Lantern Pharma's (LTRN) FDA clearance of the Investigational New Drug application for STAR-001.

Related Articles

Lantern Pharma Stock Falls 10% After FDA Clears Investigational New Drug Application For STAR-001

Nasdaq · Mar 27, 2026
Mixed

Sources

Lantern Pharma Stock Falls 10% After FDA Clears Investigational New … Nasdaq

Timeline

Last Updated Mar 27, 2026